Literature DB >> 18604921

The potential toxicity of artificial sweeteners.

Christina R Whitehouse1, Joseph Boullata, Linda A McCauley.   

Abstract

Since their discovery, the safety of artificial sweeteners has been controversial. Artificial sweeteners provide the sweetness of sugar without the calories. As public health attention has turned to reversing the obesity epidemic in the United States, more individuals of all ages are choosing to use these products. These choices may be beneficial for those who cannot tolerate sugar in their diets (e.g., diabetics). However, scientists disagree about the relationships between sweeteners and lymphomas, leukemias, cancers of the bladder and brain, chronic fatigue syndrome, Parkinson's disease, Alzheimer's disease, multiple sclerosis, autism, and systemic lupus. Recently these substances have received increased attention due to their effects on glucose regulation. Occupational health nurses need accurate and timely information to counsel individuals regarding the use of these substances. This article provides an overview of types of artificial sweeteners, sweetener history, chemical structure, biological fate, physiological effects, published animal and human studies, and current standards and regulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18604921     DOI: 10.3928/08910162-20080601-02

Source DB:  PubMed          Journal:  AAOHN J        ISSN: 0891-0162


  31 in total

1.  An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrine.

Authors:  Ousama Rachid; F Estelle R Simons; Mutasem Rawas-Qalaji; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

2.  Administration of saccharin to neonatal mice influences body composition of adult males and reduces body weight of females.

Authors:  Sebastian D Parlee; Becky R Simon; Erica L Scheller; Emilyn U Alejandro; Brian S Learman; Venkatesh Krishnan; Ernesto Bernal-Mizrachi; Ormond A MacDougald
Journal:  Endocrinology       Date:  2014-01-23       Impact factor: 4.736

Review 3.  Impact of soft drinks to health and economy: a critical review.

Authors:  J F Tahmassebi; A BaniHani
Journal:  Eur Arch Paediatr Dent       Date:  2019-06-08

4.  Cytotoxic effects of aspartame on human cervical carcinoma cells.

Authors:  Muthuraman Pandurangan; Gansukh Enkhtaivan; Doo Hwan Kim
Journal:  Toxicol Res (Camb)       Date:  2015-09-29       Impact factor: 3.524

5.  Ecotoxicological survey of MNEI and Y65R-MNEI proteins as new potential high-intensity sweeteners.

Authors:  Michele Fortunato Rega; Antonietta Siciliano; Renato Gesuele; Giusy Lofrano; Andrea Carpentieri; Delia Picone; Marco Guida
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-01       Impact factor: 4.223

Review 6.  Non-nutritive sweeteners and their role in the gastrointestinal tract.

Authors:  Rebecca J Brown; Kristina I Rother
Journal:  J Clin Endocrinol Metab       Date:  2012-06-07       Impact factor: 5.958

7.  A review of the genotoxic and carcinogenic effects of aspartame: does it safe or not?

Authors:  Serkan Yılmaz; Aslı Uçar
Journal:  Cytotechnology       Date:  2014-02-08       Impact factor: 2.058

8.  The influence of chronic intake of saccharin on rat hepatic and pancreatic function and morphology: gender differences.

Authors:  Bojana M Andrejić; Vesna M Mijatović; Isidora N Samojlik; Olga J Horvat; Jelena D Ćalasan; Matilda A Đolai
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

9.  Neurobehavioral effects of aspartame consumption.

Authors:  Glenda N Lindseth; Sonya E Coolahan; Thomas V Petros; Paul D Lindseth
Journal:  Res Nurs Health       Date:  2014-04-03       Impact factor: 2.228

10.  Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women.

Authors:  Eva S Schernhammer; Kimberly A Bertrand; Brenda M Birmann; Laura Sampson; Walter C Willett; Diane Feskanich
Journal:  Am J Clin Nutr       Date:  2012-10-24       Impact factor: 8.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.